In 2014, Yong’an was confirmed as the ‘National High-tech Enterprise’, which was re-confirmed in November 2017.
In 2017, Yong’an was awarded as the technology innovation platform by the titles of ‘Provincial Technology Center in Enterprise’ and ‘Provincial Research Center of Engineering Technology’.
After a long-term research and accumulation of technical, company has "Synthesis and Purification Technology of Dimethylpentalin", "Comprehensive Synthesis Process of Methotrexate", "Dimethylpentene Series Emulsifying Oil Compounding Process" "450g/l Dimethylpentyl Microcapsule Suspension Compounding Process" and other industry-specific and industry-leading technical expertises, which had become company’s core technical strength, effectively enhancing the comprehensive competitiveness of the company's products, and laid a solid foundation for overseas registration for bulk drug products. Several innovative projects are under development at current.
